Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2017 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2017 Results

Eagle Pharmaceuticals (EGRX) Reports In-Line Q4 EPS

February 26, 2018 6:54 AM EST

Eagle Pharmaceuticals (NASDAQ: EGRX) reported Q4 EPS of $1.00, in-line with the analyst estimate of $1.00. Revenue for the quarter came in at $46.8 million versus the consensus estimate of $52.91 million.

For earnings history and earnings-related data on Eagle Pharmaceuticals (EGRX) click here.

... More